A study evaluating efficacy of SGLT2 inhibitors in Japanese Patients with Type 2 Diabetes
Latest Information Update: 08 Aug 2021
At a glance
- Drugs Alogliptin (Primary) ; Dapagliflozin (Primary) ; Empagliflozin (Primary) ; Luseogliflozin (Primary) ; Sitagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association